NCCN Releases Statement Addressing Ongoing Chemotherapy Shortages; Shares Survey Results Finding More than 90% of Cancer Centers are Impacted

NCCN Releases Statement Addressing Ongoing Chemotherapy Shortages; Shares Survey Results Finding More than 90% of Cancer Centers are Impacted

header-info

The announcement encourages the federal government to work alongside the oncology community to develop solutions to combat these shortages. It was reported that 93% of cancer centers experienced a shortage of carboplatin and 70% report shortages of cisplatin, two of the most prominent cancer drugs.

 

Access the full press release to read more here